Log In
Print this Print this

mRNA 1851

  Manage Alerts
Collapse Summary General Information
Company Moderna Therapeutics Inc.
Description mRNA vaccine against an undisclosed viral target
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard Indication Infectious (unspecified)
Indication DetailsTreat infectious diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today